Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
_256_384.jpg)
Marksans Pharma gets USFDA nod for acid reflux drug
The agreement complements other PPAs for Sandoz production sites globally
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
Aurobindo Pharma’s US formulations revenue slipped 1.9% on a year-on-year basis to Rs. 3,488 crore
KIMS has reported total income of Rs. 878.7 crores during the period ended June 30, 2025
Revenue from operations rose 14.8 per cent year-on-year to Rs. 3,942 crore
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
Subscribe To Our Newsletter & Stay Updated
